Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Essex Woodlands Healthcare Partners

Investor type Venture Capital
Founders Jim Currie Marty Sutter

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 101
Average round size
info
The average size of a deal this fund participated in
$26M
Portfolio companies 66
Rounds per year 2.73
Lead investments 28
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.35
Exits 42
Key employees 6
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Pharmaceutical
Summary

In 1985 was created Essex Woodlands Healthcare Partners, which is appeared as VC. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Palo Alto.

Among the most popular fund investment industries, there are Biopharma, Hospital. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Inhibitex, Catalyst Biosciences, ikaSystems. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 3 or 5+ of the founder, the probability for it to get the investment is little.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Essex Woodlands Healthcare Partners, startups are often financed by SV Health Investors, Johnson & Johnson Development Corporation, Versant Ventures. The meaningful sponsors for the fund in investment in the same round are SV Health Investors, Novo Holdings, MPM Capital. In the next rounds fund is usually obtained by Johnson & Johnson Development Corporation, Novo Holdings, MPM Capital.

The usual things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2014. Opposing the other organizations, this Essex Woodlands Healthcare Partners works on 6 percentage points more the average amount of lead investments. The fund is constantly included in 2-6 investment rounds annually. The important activity for fund was in 2009. Despite it in 2019 the fund had an activity. The typical startup value when the investment from Essex Woodlands Healthcare Partners is 10-50 millions dollars. The real fund results show that this VC is 26 percentage points more often commits exit comparing to other companies.

The fund was created by Jim Currie, Marty Sutter. We also calculated 6 valuable employees in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Essex Woodlands Healthcare Partners:
Typical Co-investors
Essex Woodlands Healthcare Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Essex Woodlands Healthcare Partners:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Cardiva Medical

Health Care
Manufacturing
Medical Device
$45M14 Jul 2020 Sunnyvale, California, United States

Tissuetech

Biotechnology
Health Care
Medical
Medical Device
Pharmaceutical
$82M26 Jun 2019 Miami, Florida, United States

Xenex

Health Care
Hospital
Medical Device
Robotics
$38M24 Feb 2017 San Antonio, Texas, United States

Prolacta Bioscience

Biotechnology
Health Care
Life Science
Nutrition
$35M06 Dec 2016 California, United States

Metabolon

Biotechnology
Health Diagnostics
Software
$15M11 Aug 2016 Durham, North Carolina, United States

Suneva Medical

Health Care
Hospital
Medical
Medical Device
$25M10 Jun 2016 San Diego, California, United States

TearScience

Biotechnology
Clinical Trials
Health Care
Medical
Medical Device
$19M14 Apr 2016 North Carolina, United States

Kona Medical

Health Care
Medical
Therapeutics
$10M02 Sep 2015 Bellevue, Washington, United States

AxoGen

Biotechnology
Medical
Medical Device
$17M28 Aug 2015 Gainesville, Florida, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Essex Woodlands Healthcare Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: